Results 61 to 70 of about 27,203 (237)

Extracorporeal Methods of Detoxification in Generalized Peritonitis

Общая реаниматология, 2008
Objective: to optimize the results of treatment in patients with generalized peritonitis. Sixty-eight patients were examined. In Group 1 (n=26), plasmapheresis was performed during traditional therapy; in Group 2 (n=28) plasmapheresis was combined with ...
O. M. Shevtsova, N. V. Shapovalova, A. A. Lavrentyev, T. V. Beloshevskaya, V. N. Mishchuk   +4 more
doaj   +1 more source

The comparison of the mortality rates of plasmapheresis/hemoperfusion therapy with current treatment among Covid-19 patients

Heliyon, 2022
Background: There is no definitive treatment for COVID-19. Hemoperfusion and plasmapheresis have only been studied in a few cases of COVID-19. In this study, plasmapheresis-hemoperfusion and current treatment for COVID-19 patients were compared for ...
Seyede Mahboobeh Raoofi Kelachayeh, Maryam Haddadzadeh Shoushtari, Zahra Mehraban, Mehrdad Dargahi-Malamir, Gholamreza Alizadehattar, Hanieh Raji   +5 more
doaj  

Impact of Vitamin E‐Coated Membrane Hemodiafilter on Serum Albumin Redox State in the Acute Kidney Injury Pig Hemodialysis Model

Artificial Organs, EarlyView.
The effect of vitamin E‐coated high‐flux hemodiafilter on the redox state of serum albumin, which forms the largest fraction of reactive sulfhydryl, has not been reported. Hemodiafiltration (HDF) with (V‐RATM) and without a vitamin E‐coated hemodiafilter (ABHTM) was performed in an acute kidney injury pig model to determine whether changes in the serum
Shouichi Fujimoto, Masahide Koremoto, Shushi Yamamoto, Hiroshi Umeno, Yusuke Sano, Toshihiro Tsuruda   +5 more
wiley   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Use of plasmapheresis in women with placenta isufficiency after IVF

RUDN Journal of Medicine, 2010
The effect of plasmapheresis is studied at placentary insufficiency at 120 women after IVF with placenta isufficiency. The age of investigated women was from 26 to 41 years, average 33,4 ± 4,6 years.
F B Buranova, O V Rogachevskiy
doaj  

Diagnostic testing and treatment in Japanese patients with a diagnosis code for chronic inflammatory demyelinating polyradiculoneuropathy: A claims database analysis

Clinical and Experimental Neuroimmunology, EarlyView.
Abstract Objectives Reports of real‐world data concerning chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are limited in Japan. This study aimed to investigate the diagnostic testing and treatment performed in patients diagnosed with CIDP in Japan. Methods Using a Japanese commercial medical information database, we analyzed diagnostic
Motoi Kuwahara, Susumu Kusunoki, Ataru Igarashi, Satoshi Akiyama, Taku Fukushima, Mamoru Doi   +5 more
wiley   +1 more source

Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study

European Journal of Clinical Investigation, EarlyView.
The findings demonstrated no significant difference in MACE between the sirolimus‐treated and untreated groups (hazard ratio, 1.40; 95% confidence interval, .77–2.55), despite a higher incidence of dyslipidaemia in the sirolimus‐treated group. However, subgroup analysis indicated an increased MACE risk in KTRs with pre‐transplant congestive heart ...
Jinhyun Park, Wonhui Choi, Jinseub Hwang, Ha Young Jang, Yun Kim, Young‐Mi Ah, Jin‐Won Kwon, Kyung Hee Choi, Yun‐Kyoung Song   +8 more
wiley   +1 more source

Advancements in multiple sclerosis

Internal Medicine Journal, EarlyView.
Abstract The global prevalence of multiple sclerosis (MS) is increasing, and early diagnosis and treatment is essential in mitigating disability. While recent therapeutic advancements have significantly reduced relapse rates, the progressive and degenerative aspects of MS continue to pose major challenges.
Turlough Montague, James Drummond, Karl Ng, John Parratt   +3 more
wiley   +1 more source

Dataset concerning haematological and biochemical parameters changes in show jumping horses subjected to exercise and plasmapheresis session

Data in Brief, 2019
This article presents data on the effect of plasmapheresis on clinical, haematological and biochemical parameters in horses following exercise and after a plasmapheresis session.
Réda Daden, Sara Chbihi, Fatima Zahraa Zarhouni, Jamal Chakir, Mohammed Piro, Mohamed Rachid Achaaban, Mohammed Ouassat, Khalid El Allali   +7 more
doaj  

Plasma cell‐directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema

Journal of the European Academy of Dermatology and Venereology, EarlyView.
In severe forms of monoclonal gammapathy associated with scleromyxoedema with dermatoneuro syndrome and/or cardiac involvement, deep and durable responses allowing IVIG withdrawal could be achieved using anti‐plasma cell therapy, including Imids, anti‐CD38 or proteasome inhibitors. Abstract Background Scleromyxedema (SM) is a rare skin disorder related
F. Theves, C. Lahuna, T. Mahévas, S. Harel, B. Royer, V. Lemiale, A. Brignier, N. Parquet, M. Jachiet, J.‐D. Bouaziz, D. Elessa, B. Arnulf, A. Talbot   +12 more
wiley   +1 more source